These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11768874)

  • 1. Can advocates keep congress focused on HIV?
    AIDS Alert; 2001 Dec; 16(12):157-8. PubMed ID: 11768874
    [No Abstract]   [Full Text] [Related]  

  • 2. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV drugs. New Congress could create hurdles for drug patents.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014
    [No Abstract]   [Full Text] [Related]  

  • 4. The Claritin case: how one firm played the patent game.
    Novak V
    Time; 1999 Nov; 154(21):42. PubMed ID: 10622840
    [No Abstract]   [Full Text] [Related]  

  • 5. TRIPS: generic irony.
    Howarth GR
    Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
    [No Abstract]   [Full Text] [Related]  

  • 6. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 7. International patent protection for HIV-related therapies: patent attorney's perspective.
    Pavento LC; Greene JL; McDonald JK
    Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 9. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 10. US concedes on cheaper drug production in Brazil.
    Gottlieb S
    BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440934
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS group takes aim at pharmaceutical firm's patents, prices.
    AIDS Policy Law; 2002 Jul; 17(13):4. PubMed ID: 12162289
    [No Abstract]   [Full Text] [Related]  

  • 12. Advocates praise Schwarzenegger for fully funding ADAP.
    AIDS Policy Law; 2006 Jan; 21(2):9. PubMed ID: 16479677
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS advocates returning to their activism roots. Protesters welcome arrests and publicity.
    AIDS Alert; 2004 Aug; 19(8):90-3. PubMed ID: 15300946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critics denounce Bush's proposed budget for HIV prevention and care.
    AIDS Alert; 2002 Apr; 17(4):41, 43-5. PubMed ID: 12030198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. Congress to consider vaccine-focused legislation.
    IAVI Rep; 2007; 11(1):19. PubMed ID: 20210122
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug patents cause fresh spat between South Africa and industry.
    Jack A
    BMJ; 2014 Feb; 348():g1377. PubMed ID: 24511092
    [No Abstract]   [Full Text] [Related]  

  • 17. Gore's humanitarianism loses out to strong-arm tactics.
    Nature; 1999 Jul; 400(6739):1. PubMed ID: 10403233
    [No Abstract]   [Full Text] [Related]  

  • 18. Activists dialog about pricing.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247. PubMed ID: 10351896
    [No Abstract]   [Full Text] [Related]  

  • 19. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 20. Groundswell.
    Karch G
    GMHC Treat Issues; 2003 Dec; 17(12):12. PubMed ID: 15011649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.